Skip to main content

Sub-panels for hereditary cancers

The panels include genes selected by following medically accepted guidelines and can be collected using saliva, blood, or fibroblast.

Test name

Test code

GSP or CPT coding


Hereditary Breast Cancer Panel (18 genes)
Tests for variants in 18 genes predominantly associated with cancers of the breast, prostate, and other tissues, including: ATM, BARD1, BRCA1, BRCA2, CDH1, CHEK2, EPCAM, MLH1, MSH2, MSH6, NF1, PALB2, PMS2, PTEN, RAD51C, RAD51D, STK11, TP53



81432, 81433


Hereditary Colorectal Cancer Panel (20 genes)
Tests for variants in 20 genes associated with increased risk for colorectal cancer including: APC, AXIN2, BMPR1A, CDH1, CHEK2, EPCAM, GREM1, MLH1, MSH2, MSH3, MSH6, MUTYH, NTHL1, PMS2, POLD1, POLE, PTEN, SMAD4, STK11, TP53


81435, 81436


Hereditary Endocrine Cancer Panel (12 genes)
Tests for variants in 12 genes associated with increased risk for paragangliomas, pheochromocytomas, and endocrine cancer: FH, MAX, MEN1, NF1, RET, SDHA, SDHAF2, SDHB, SDHC, SDHD, TMEM127, VHL


81437, 81438


BRCA Panel Plus (7 genes)
Detects variants in BRCA1, BRCA2, CDH1, PALB2, PTEN, STK11, TP53


81162, 81307, 81321, 81323, 81351, 81404, 81405, 81406, 81479


Hereditary cancer genetic testing guide

Download our hereditary cancer reference guide for an overview of our tests, genes included in each test, and associated cancers (gene association based on guidelines and internal data).

Test codes may vary by location. Please contact your local laboratory for more information.

Components of panels may be ordered separately.

The CPT® codes provided are based on American Medical Association guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

Helping you understand test results

We have created reports to help you and your patients better understand hereditary cancer test results.

Only a patient’s treating physician can make diagnoses, prognostic or treatment decisions based on the knowledge of the patient, history and clinical/educational experience. Quest lab testing provides information for the physician to use in helping make such decisions.